AstraZeneca Pharma India is planning to sell its 64-acre manufacturing facility in North Bengaluru, as the UK-based parent company reviews its global supply and manufacturing network. The strategic move forms part of AstraZeneca’s broader effort to optimize assets and streamline global operations, while also unlocking value from high-value real estate holdings.
Deal Could Fetch Around ₹3,400 Crore
According to industry sources, the land parcel could fetch around ₹3,400 crore, reflecting the strong demand for premium land in North Bengaluru. The property is estimated to be valued at more than ₹53 crore per acre due to its prime location and development potential. The site has already attracted interest from several major players, including Sattva Group, Aurobindo Pharma, and RMZ. A person familiar with the development said the company has shortlisted three potential bidders and is expected to finalize the transaction soon.
Shift from Manufacturing Asset to Real Estate Development
Earlier, AstraZeneca had explored the possibility of selling the facility as a running manufacturing asset. The company had sought buyers who could continue operating the site as a contract manufacturing organization (CMO) for products currently produced or packaged there, subject to regulatory approvals. However, the company has now shifted its strategy. It plans to divest the land outright, allowing the buyer to develop residential and commercial projects on the site. Previous attempts to sell the property faced hurdles due to high valuation expectations, sources indicated.
Strategic Role of AstraZeneca’s Bengaluru Facility
The Bengaluru facility is part of AstraZeneca’s global network of research and operations centres. It is one of nine international sites focused on areas such as clinical trial design, safety monitoring and regulatory compliance. AstraZeneca Pharma India, established in 1979, is headquartered in Bengaluru and continues to play an important role in the company’s global operations.
Rising Trend of Corporate Land Monetization
As reported by realtydailynews.com, the proposed sale also reflects a growing trend of companies monetizing non-core land assets. As real estate prices continue to rise in major Indian cities, several companies are choosing to unlock value from underutilized land holdings. Cities such as Mumbai, Delhi, Bengaluru, Hyderabad, Chennai, and Pune have witnessed increased activity in corporate land transactions. At the same time, real estate developers are actively looking to replenish their land banks. Leading developers, including Godrej Properties and Prestige Group, have recently completed several high-value land acquisitions to support future residential and commercial projects.
